Nevertheless, the evidence that metabolic rewiring is a crucial and novel cancer hallmark [52,56], and that HSP90 chaperones have a central role in cellular adaptive pathways and in the crosstalk between epigenetic and metabolic pathways favoring metabolic rewiring, still support the strategy to inhibit HSP90 to target metabolism/epigenetic crosstalk. This evidence concerns the gene HSP90AA1 and cancer.